Wearable Tremor Therapy Market Size, Share, and COVID-19 Impact Analysis, By Anatomical Location (Wrist, Hand, and Others), By Product Type (Mechatronics Systems, Handheld External Devices, and Orthosis), By Distribution Channel (Hospital and Retail Pharmacies, Online Stores, and Others), and Regional Forecast 2025-2032

Wearable tremor therapy is a non-invasive solution for tremor management. It is a superior alternative for surgical procedures that causes nonreversible brain lesions. These wearable technologies suppress tremors by modifying the limb biomechanics and not targeting their site of origin. Such devices offer lifestyle interventions and focus on providing ease to the patients while performing their activities of daily living (ADLs).

An increase in the number of patients suffering from neurological diseases, such as epilepsy, Parkinson's disease, and essential tremors, among others, is one of the prime factors contributing to the growth of the wearable tremor therapy market.

• According to data published by the World Health Organization (WHO) in 2023, the prevalence of Parkinson's disease (PD) has doubled in the past 25 years, with over 8.5 million individuals globally suffering from PD in 2019. Furthermore, it is estimated that globally 5.0 million people are diagnosed with epilepsy on an annual basis. It is one of the most common neurological diseases worldwide, with around 50.0 million patients suffering.

Additionally, due to the several existing side effects of the anti-epileptic drugs, patients tend to shift their choice of treatment from medications to wearable tremor devices for temporary relief. This preferential shift over time is expected to fuel the market growth.

• For instance, as per the data mentioned in WebMD LLC, in 2023, some of the dangerous long-term side effects of anti-epileptic drugs includes bone thinning, liver damage, decreased platelets (clotting cells), hearing issues, and pancreatic problems.

However, less awareness of the advanced therapies for tremors among people impacts the adoption of these devices. The limited efficacy of these products among the patients hinders the usage of the products, affecting the growth of the market.

Impact of COVID-19 on the Wearable Tremor Therapy Market

In 2020, the wearable tremor therapy market faced a negative impact amid the COVID-19 pandemic. This was due to manufacturing challenges across the globe. Due to the economic impact, health tech companies operating in the wearable tremor therapy market slowed their research initiatives. Moreover, the period also recorded a decline in patient visits due to restrictions. However, during this time, it was observed that patients with epilepsy had a rise in seizure frequencies. This led to an increasing demand for tremor-reducing devices, supporting market growth.

Segmentation

Key Insights

The report covers the following key insights:

• Prevalence of Key Neurological Disorders, By Key Countries/Regions, 2022
• Key Industry Developments
• Overview of Key Startup Companies in the Market
• Impact of COVID-19 on the Wearable Tremor Therapy Market

Analysis by Anatomical Location

Based on anatomical location, the wrist segment accounted for a significant proportion of the global wearable tremor therapy market in 2022. The growth was mainly attributed to such devices' constant innovation and development and the focus on gaining funds to treat or reduce patient tremors. Similarly, the strong prevalence of neurological disease and the growing adoption of health tech products drive the market growth.

• In September 2020, Encora Therapeutics secured USD 1.5 million in the pre-seed round. It is a startup company developing wearable devices to reduce tremors and benefit patients through ease in daily tasks.

Regional Analysis

To gain extensive insights into the market, Download for Customization

North America dominated the wearable tremor therapy market in 2022 and is projected to maintain its position over the forecast period. The growth is mainly attributed to the presence of domestic companies in the U.S. that have launched these tremor-reducing devices. These manufacturers are playing an active role in gaining regulatory approvals for the commercialization of the product, accelerating the market growth.  

• For instance, in June 2023, Cala Health launched its next-generation Cala kIQ System to relieve hand tremors in people with essential tremors and Parkinson’s disease. It is a Food and Drug Administration (FDA) cleared device that delivers Transcutaneous Afferent Patterned Stimulation (TAPS) through it and temporarily relieves postural and kinetic tremor symptoms.

Key Players Covered

The report includes the profiles of key players such as Cala Health, Inc., Allevion Therapeutics, Steadiwear Inc., STIL, Five Microns, Neater Solutions Ltd., Lift Labs, Encora Therapeutics, and others.

Key Industry Developments

• In March 2022, Allevion Therapeutics announced its successfully evaluation of the Allevx device in the U.S. The device is clinically tested in 14 patients having movement disorder conditions such as essential tremor and Parkinson's disease. All the patients had reduced tremors after going through the therapy.
• In March 2021, Encora Therapeutics gained Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its tremor-reducing wristband indicated to relieve hand tremors in adult essential tremors or Parkinson's patients.
• In April 2017, Klick Labs introduced its first device, SymPulseTM Tele-Empathy Device, to record and transmit Parkinson’s tremors in real time to enable physicians and family members to experience the patient's difficulties. The device records continuous electromyogram data from the patient and transmits it through Bluetooth to an electrical muscle stimulation armband for non-patients.